e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Introduction: The need for better diagnostics for tuberculosis in Europe
E. Huitric (Stockholm, Sweden)
Source:
Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Session:
Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Session type:
Oral Presentation
Number:
2146
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Huitric (Stockholm, Sweden). Introduction: The need for better diagnostics for tuberculosis in Europe. Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Introduction: The burden of tuberculosis drug resistance in Eastern Europe: the Moldavian experience
Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2010
Paediatric tuberculosis in Europe: lessons from Denmark and inclusive strategies to consider
Source: Eur Respir J 2014; 43: 678-684
Year: 2014
Will clinicians keep their place in modern management of tuberculosis?
Source: Eur Respir J 2001; 18: Suppl. 33, 474s
Year: 2001
Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice
Source: Eur Respir J 2011; 37: 1175-1182
Year: 2011
Towards the elimination of tuberculosis: challenges ahead from a European perspective
Source: Annual Congress 2012 - Joint session with WHO and ECDC "Towards elimination of tuberculosis"
Year: 2012
The new horizons of molecular diagnosis: do we still need conventional microbiology?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
The European Union standards for tuberculosis care: do they need an update?
Source: Eur Respir J 2014; 43: 933-942
Year: 2014
The new era of diagnostics: will it ever start?
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019
Fate or missed opportunities - challenges in diagnosing paediatric drug resistant tuberculosis in Germany
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021
Opportunities of bacteriological diagnostics of a tuberculosis of a lung in a modern stage
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008
Introduction and basic epidemiology
Source: Online Course 2014 - Respiratory epidemiology
Year: 2014
Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Source: Eur Respir J 2010; 36: 1242-1247
Year: 2010
TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
Introduction: Pulmonary rehabilitation – strong foundations, new science and opportunities for innovation
Source: Eur Respir Monogr 2021; 93: ix-xiii
Year: 2021
TB elimination: theory and practice in Europe
Source: School Course 13
Year: 2013
MDR-TB management: what is new?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Precision medicine in tuberculosis treatment – a role for pharmacogenetics?
Source: International Congress 2018 – Challenges in tuberculosis care
Year: 2018
New opportunities in tuberculosis control
Source: Eur Respir J 2012; 39: 1271-1273
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept